Terri Sebree Net Worth & Insider Trades
Terri Sebree - President, Zynerba Pharmaceuticals, Inc
What is Terri Sebree's Net Worth?
The current estimated net worth of Zynerba Pharmaceuticals, Inc's President, Terri Sebree, is estimated to be about $98.31K . Terri Sebree owns about 513,204 units of Zynerba Pharmaceuticals, Inc common stock. In the last 8 years at Zynerba Pharmaceuticals, Inc, Terri Sebree has sold an estimated value of $35.35K worth.
What is Terri Sebree's Past Insider Trading?
Terri Sebree's largest purchase order was 3,800 units , worth over $22.01K on August 7, 2018. Terri Sebree's largest sale order was 24,661 units , worth over $14.74K on January 25, 2023. In total, Terri Sebree has made about 12 transactions over 8 years of their time at Zynerba Pharmaceuticals, Inc. Terri Sebree usually trades in January, with the busiest year in 2023.
Terri Sebree
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Terri Sebree's Salary in 2020?
As President of Zynerba Pharmaceuticals, Inc, Terri Sebree has a total base salary of $450,883 . Terri Sebree received compensation valued at about $1,115,652 in 2020 after becoming President. The vast majority of their compensation came in the form of other earnings, plans or compensations of $209,660 , option awards of $428,858 , and other compensation of $26,251 .
What is Terri Sebree's' Mailing Address?
- Mailing address is Zynerba Pharmaceuticals, Inc. 80 W. Lancaster Avenue, Suite 300 Devon PA 19333 PA
Zynerba Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Armando Anido | 2020 | $585,265 | $263,369 | - | $580,674 | $53,441 | $1,482,749 |
| Armando Anido | 2019 | $568,218 | $334,112 | - | $413,149 | $54,092 | $1,369,571 |
| Terri B. Sebree | 2020 | $450,883 | $209,660 | - | $428,858 | $26,251 | $1,115,652 |
| Terri B. Sebree | 2019 | $437,750 | $252,144 | $13,140 | $309,861 | $25,985 | $1,038,880 |
| James E. | 2020 | $409,932 | $129,129 | - | $303,775 | $43,763 | $886,599 |
| James E. | 2019 | $390,411 | $158,347 | - | $227,487 | $47,862 | $824,107 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1621443/000110465921052876/tm2111207-2_def14a.htm
What are Zynerba Pharmaceuticals, Inc's Past Insider Trades?
Zynerba Pharmaceuticals, Inc's most recent insider trade came on February 17, 2023 by Albert P Parker who sold 3,173 units worth $1.72K . In the last 8 years, insiders at Zynerba Pharmaceuticals, Inc have sold an estimated value of $167.28K and bought an estimated value of $2.45M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Kenneth Moch, Director, Armando Anido, Chairman & Chief Exec. Officer, and James Fickenscher, Chief Financial Officer .
Zynerba Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||